Pacific Biosciences of California Inc (NAS:PACB)
$ 1.86 -0.07 (-3.63%) Market Cap: 568.03 Mil Enterprise Value: 1.02 Bil PE Ratio: 0 PB Ratio: 1.17 GF Score: 55/100

Pacific Biosciences of California Inc at JPMorgan Healthcare Conference (Virtual) Transcript

Jan 14, 2021 / 07:00PM GMT
Release Date Price: $37.72 (+9.81%)
Tycho W. Peterson
JPMorgan Chase & Co, Research Division - Senior Analyst

All right. Great. We're going to kick it off with our next company this afternoon, Pacific Biosciences. Before I turn it over to Christian, just a quick reminder if people have questions to submit them through the website.

And with that, I'll turn it over to Christian.

Christian O. Henry
Pacific Biosciences of California, Inc. - President, CEO & Director

Thanks, Tycho, and I'd like to thank JPMorgan for the opportunity to present in front of you today. But first, I want to go through our safe harbor statement to remind folks that you can get more information about our company on the website, and in fact, we might be making some forward-looking statements today. So please be aware of that, and refer to our website and the SEC website if you have further concerns or questions.

I want to tell you a little bit about Pacific Biosciences. I joined the company in September of this past year, and we've made a lot of progress. So today, I'll talk a little bit about

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot